2rgu
From Proteopedia
Line 1: | Line 1: | ||
[[Image:2rgu.jpg|left|200px]] | [[Image:2rgu.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_2rgu", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_2rgu| PDB=2rgu | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''Crystal structure of complex of human DPP4 and inhibitor''' | '''Crystal structure of complex of human DPP4 and inhibitor''' | ||
Line 29: | Line 26: | ||
[[Category: Himmelsbach, F.]] | [[Category: Himmelsbach, F.]] | ||
[[Category: Nar, H.]] | [[Category: Nar, H.]] | ||
- | [[Category: | + | [[Category: Aminopeptidase]] |
- | [[Category: | + | [[Category: Glycoprotein]] |
- | [[Category: | + | [[Category: Hydrolase]] |
- | [[Category: | + | [[Category: Inhibitor]] |
- | [[Category: | + | [[Category: Membrane]] |
- | [[Category: | + | [[Category: Peptidase]] |
- | [[Category: | + | [[Category: Protease]] |
- | [[Category: | + | [[Category: Secreted]] |
- | [[Category: | + | [[Category: Serine protease]] |
- | [[Category: | + | [[Category: Signal-anchor]] |
- | [[Category: | + | [[Category: Transmembrane]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 16:53:18 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 13:53, 4 May 2008
Crystal structure of complex of human DPP4 and inhibitor
Overview
A new chemical class of potent DPP-4 inhibitors structurally derived from the xanthine scaffold for the treatment of type 2 diabetes has been discovered and evaluated. Systematic structural variations have led to 1 (BI 1356), a highly potent, selective, long-acting, and orally active DPP-4 inhibitor that shows considerable blood glucose lowering in different animal species. 1 is currently undergoing clinical phase IIb trials and holds the potential for once-daily treatment of type 2 diabetics.
About this Structure
2RGU is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin -2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes., Eckhardt M, Langkopf E, Mark M, Tadayyon M, Thomas L, Nar H, Pfrengle W, Guth B, Lotz R, Sieger P, Fuchs H, Himmelsbach F, J Med Chem. 2007 Dec 27;50(26):6450-3. Epub 2007 Dec 1. PMID:18052023 Page seeded by OCA on Sun May 4 16:53:18 2008